soul trial oral semaglutide cardiovascular outcomes 2024 nejm results

soul trial oral semaglutide cardiovascular outcomes 2024 nejm results Effects of Semaglutide on Heart Failure Outcomes in Diabetes and Chronic Kidney Disease in the FLOW Trial NEJM Editorial Fellow Harleen Marwah,

Name: soul trial oral semaglutide cardiovascular outcomes 2024 nejm results Effects of Semaglutide on Heart Failure Outcomes in Diabetes and Chronic Kidney Disease in the FLOW Trial NEJM Editorial Fellow Harleen Marwah,
Brand: roaa.app
SKU: 94813150834
Price: 28.29 USD
Availability: InStock
Rating: 4.1836 (28 reviews)

SKU: 94813150834

4.2

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 23 - Aug 28

Description

Given how these medications are currently used, there is currently no demonstrable return on investment (ROI) within the pharmacy benefit for employer health plans that cover GLP-1s for weight loss at the current price

A 58% reduction is extraordinary